1. Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics
   Anna D. Louie et al, 2021, Frontiers in Pharmacology CrossRef
2. The Predictive Biomarkers of Immune Checkpoint Inhibitors in the Treatment of Lung Cancer
   轩超 贾, 2024, Advances in Clinical Medicine CrossRef
3. Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy
   Anton Kraxner et al, 2024, Frontiers in Immunology CrossRef
4. Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy
   Jair Bar et al, 2024, Frontiers in Immunology CrossRef
5. Prognostic significance of tumor infiltrating lymphocytes on first-line pembrolizumab efficacy in advanced non-small cell lung cancer
   Kyoichi Kaira et al, 2023, Discover Oncology CrossRef
6. Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer
   Max Backman et al, 2023, European Journal of Cancer CrossRef
7. Peripheral Blood CD8+ CD28+ T Cells as an Independent Predictor of Treatment Response and Survival After Concurrent Chemoradiotherapy in Pediatric High-Grade Glioma Patients
   Shuo Wang et al, 2024, Clinical Medicine Insights: Oncology CrossRef
8. Tumor-infiltrating lymphocyte therapy for lung cancer and its future paradigms
   Ali Nowroozi et al, 2022, Expert Opinion on Biological Therapy CrossRef
9. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy
   Hui Li et al, 2021, Technology in Cancer Research & Treatment CrossRef